Ravi Patel

Ravi Patel, RPh, PharmD, MBA, is an experienced leader in pharmacovigilance and quality compliance, currently serving as Senior Vice President at United Therapeutics Corporation since August 2016, focusing on ensuring safe manufacturing and utilization of medicinal products for PAH patients. With a robust career, Ravi previously held roles at Temple University as an Adjunct Professor and at Alexion Pharmaceuticals as Executive Director of Global Pharmacovigilance and Drug Safety Operations. Early career experience includes significant positions at CVS Health, Glenmark Pharmaceuticals, and Bayer HealthCare, where Ravi made notable contributions to the expansion and transformation of global pharmacovigilance strategies. Ravi holds a PharmD from Long Island University and an MBA from Montclair State University.